Guideline version conflicts during global harmonization – alignment with ICH expectations
When guideline version conflicts arise, several symptoms may become apparent across production sites and laboratories:Click to read the full article.
Tips for Regulatory Compliance & Quality Systems
Risk management inconsistent during global harmonization – alignment with ICH expectations
Identifying symptoms of risk management inconsistencies is paramount for swift interventions. Symptoms can manifest in various ways depending on departmental focus. Below are common signals across the pharmaceutical manufacturing lifecycle:Click…
Risk management inconsistent during submission – regulatory gap analysis
Recognizing early signs of risk management inconsistencies is crucial for timely intervention. Symptoms may vary, but common indicators include:Click to read the full article.
Risk management inconsistent during inspection – regulatory gap analysis
Recognizing symptoms of inconsistent risk management is critical. Common signals may include:Click to read the full article.
QbD elements not implemented during inspection – alignment with ICH expectations
Addressing Non-Implementation of QbD Elements in Inspections: A Practical Guide In the highly regulated landscape of pharmaceutical manufacturing, the failure to implement Quality by Design (QbD) elements can result in…
QbD elements not implemented during inspection – preventing repeat global findings
Identifying symptoms or signals early during operations can drastically reduce the impact of underlying QbD deficiencies. Symptoms may manifest in several ways:Click to read the full article.
QbD elements not implemented during development – regulatory gap analysis
Identifying symptoms of missing QbD elements during development can take various forms across production, quality control, and regulatory compliance functions. Here are several signs to monitor:Click to read the full…
Lifecycle approach missing during submission – inspection questioning scenarios
Identifying the right symptoms is paramount to diagnosing issues associated with a missing lifecycle approach. Common signals that practitioners should look for include:Click to read the full article.
Risk management inconsistent during inspection – alignment with ICH expectations
Recognizing symptoms of risk management inconsistencies is vital for effective quality assurance. Key signals that may indicate potential issues include:Click to read the full article.
Lifecycle approach missing during inspection – preventing repeat global findings
Identifying potential gaps in lifecycle management during routine operations is crucial. Common symptoms include:Click to read the full article.
ICH guideline misinterpretation during submission – inspection questioning scenarios
Identifying compliance issues early is crucial. Common symptoms that may indicate misinterpretation of ICH guidelines include:Click to read the full article.
QbD elements not implemented during lifecycle management – regulatory gap analysis
Identifying the root causes of the deficiencies observed can be structured around the classic 5M categories: Materials, Method, Machine, Man, Measurement, and Environment.Click to read the full article.